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R E S E A R C H A R T I C L E
High-Sugar,butNotHigh-Fat, FoodActivatesSupraoptic
Nucleus Neurons in the Male Rat
Catherine Hume,1 Nancy Sabatier,1 and John Menzies1
1Centre for Integrative Physiology, School of Biomedical Sciences, University of Edinburgh, Edinburgh EH8
9XD, United Kingdom
Oxytocin is a potent anorexigen and is believed to have a role in satiety signaling. We developed rat
models to study the activity of oxytocin neurons in response to voluntary consumption or oral gavage
of foods using c-Fos immunohistochemistry and in vivo electrophysiology. Using c-Fos expression as an
indirect marker of neural activation, we showed that the percentage of magnocellular oxytocin
neurons expressing c-Fos increasedwith voluntary consumption of sweetened condensedmilk (SCM).
Tomodel the effect of food in the stomach, we gavaged anesthetized rats with SCM. The percentage
of supraoptic nucleus and paraventricular nucleus magnocellular oxytocin-immunoreactive neurons
expressing c-Fos increased with SCM gavage but not with gastric distention. To further examine the
activity of the supraoptic nucleus, wemade in vivo electrophysiological recordings fromSONneurons,
where anesthetized rats were gavaged with SCM or single cream. Pharmacologically identified
oxytocin neurons responded to SCM gavage with a linear, proportional, and sustained increase in
firing rate, but cream gavage resulted in a transient reduction in firing rate. Blood glucose increased
after SCM gavage but not cream gavage. Plasma osmolarity and plasma sodium were unchanged
throughout.We showthat in response tohigh-sugar, but nothigh-fat, food in the stomach, there is an
increase in the activity of oxytocin neurons. This does not appear to be a consequence of stomach
distention or changes in osmotic pressure. Our data suggest that the presence of specific foods with
different macronutrient profiles in the stomach differentially regulates the activity of oxytocin
neurons. (Endocrinology 158: 2200–2211, 2017)
Oxytocin is an anorexigen synthesized in neuronsof the hypothalamic supraoptic nucleus (SON)
and paraventricular nucleus (PVN). The SON and PVN
contain magnocellular oxytocin neurons that project to
the posterior pituitary and secrete their products into the
circulation. These neurons can also secrete large amounts
of oxytocin from their dendrites to act at multiple and
diverse brain targets (1–3); a few also send axonal pro-
jections to forebrain areas, including the amygdala (4). In
addition to magnocellular oxytocin cells, the PVN con-
tains a population of parvocellular oxytocin neurons that
project centrally.Many of these neurons project to caudal
brainstem regions, including the nucleus of the solitary
tract (NTS), a region involved in regulation of the gas-
trointestinal vago-vagal reflex and gastric emptying
(5, 6). Oxytocin fibers also innervate the arcuate nucleus
(ARC) (7).
There is robust evidence from rodent models that
oxytocin is powerfully anorexigenic. Central oxytocin
administration dose-dependently decreases voluntary
food intake, and this is dependent on the oxytocin re-
ceptor (8–10). There is also considerable evidence of a
role for both magnocellular and parvocellular oxytocin
neurons in the physiological response to food con-
sumption. Expression of the immediate early gene c-Fos
in magnocellular oxytocin neurons of the SON is in-
creased by food intake and associated stimuli, such as
refeeding after fasting (11), palatable food consumption
(12), changes in osmotic pressure (13), gastric distention
(14), and systemic administration of the satiety mediators
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cholecystokinin (CCK) (15), secretin (16), and leptin (17).
Magnocellular oxytocin neurons coexpress several other
anorexigenic peptides, most conspicuously CCK (18) and
nesfatin (19). They express melanocortin MC4 receptors
and respond to direct application of a-melanocyte
stimulating hormone (a-MSH) by releasing oxytocin
from their dendrites (20). Oxytocin receptors are
expressed at a very high density in the ventromedial
nucleus of the hypothalamus (VMH) and in the amyg-
dala, which are brain regions that contain very few
oxytocin fibers and hence are thought to be likely targets
of dendritically released oxytocin, acting as a neuro-
hormone. More recently, it has been suggested that
oxytocin signaling may be especially relevant to hedonic
food choice and consumption, particularly sugar con-
sumption (21–23).
The effect of food or nutrient consumption on the
electrical activity of oxytocin neurons is relatively un-
explored, either via gut-derived hormonal or vagal sig-
naling or via oro-sensory signaling (12, 24). Therefore,
we hypothesized that the activity of oxytocin neurons
could be increased in vivo by gut-brain signaling when
food [sweetened condensed milk (SCM)] is consumed
voluntarily or delivered directly into the stomach by
gavage in anesthetized rats. We tested this using c-Fos
immunohistochemistry and in vivo electrophysiology,
recording from neurons in the SON. Furthermore, we
investigated whether the delivery of an isocaloric food
with a different macronutrient profile to SCM (low-
sugar, high-fat single cream) directly into the stomach
differentially influences the electrical activity of oxytocin
neurons.
Materials and Methods
All behavioral and surgical procedures were carried out under
UK Home Office regulations and after approval from the local
ethical committee. Male adult Sprague-Dawley rats (8 to
10 weeks old) were kept on a 12-h light cycle (lights on at 7:00
AM) at 206 1°C and given ad libitum access to water and food
(RM1; Special Diet Services, Essex, UK). A volume of 5 mL of
SCM (diluted 50%v/v inwater; 40.8 kJ, 0.24 g fat, 1.68 g sugar)
(Nestle´, UK) or single cream (40.6 KJ, 0.955 g fat, 0.11 g sugar)
was used. Single cream was used because it is isocaloric to SCM
but has a higher fat and lower sugar content. All reagents were
obtained from Sigma (UK) unless otherwise stated.
Experiment 1: c-Fos–like immunohistochemistry
after voluntary SCM consumption
Sixteen male rats were singly housed. Eight rats were
assigned to a control group and were not given SCM. Eight rats
were schedule-fed SCM, receiving 15 minutes of SCM access at
the same point in the early light phase for 8 days (“SCM access”
group). On day 8, six rats consumed the SCM. Two rats did not
consume the SCM and were excluded from further analysis.
On the final day of SCM scheduled feeding, 1 h after SCM
access, rats were euthanized with an overdose of pentobarbital
given intraperitoneally (IP) followed by transcardial perfusion
with ice-cold saline containing 0.012%w/v heparin followed by
4% w/v paraformaldehyde in 0.1 M phosphate buffer. Brains
were removed, postfixed, cryo-protected, frozen on dry ice, and
cut serially on a freezing microtome at 44 mm in the coronal
plane. All sections were processed for c-Fos–like immunore-
activity using an anti–c-Fos rabbit primary antibody
(1:100,000) (226 003; Synaptic Systems, Germany) and bio-
tinylated horse anti-rabbit immunoglobulin G (IgG) secondary
antibody (1:500) (BA-1100; Vector Laboratories, UK) as de-
scribed previously (25). A subset of sections were double stained
using anti–oxytocin-neurophysin (1:5000) (PS 38; supplied by
H. Gainer, Bethesda, MD) mouse primary antibody or anti-
tyrosine hydroxylase (TH) (1:20,000) (MAB318; Merck
Millipore, UK) mouse primary antibody and biotinylated horse
anti-mouse IgG secondary antibody (1:500) (BA-2000; Vector
Laboratories). Table 1 lists the antibodies used. Positive control
brain sections from rats given a hyperosmotic stimulus (3.5 M
NaCl 600 mL/kg, IP) were used. We observed dense c-Fos ex-
pression in the SON and PVN, indicating that the primary
antibody was selective and sensitive. Negative control rat brain
sections incubated with preimmunized rabbit (for c-Fos) or
mouse (for oxytocin-neurophysin or TH) serum showed no
immunoreactivity. Preabsorption control rat brain sections
incubated with preabsorbed c-Fos primary antibody (c-Fos
antibody incubated overnight with an excess of purified
c-Fos peptide) (226-0P; Synaptic Systems) also showed no
immunoreactivity.
Brain sections were mounted on gelatin-coated slides and
dehydrated in alcohol followed by xylene. Coverslips were
applied using DPX mounting medium and viewed using a re-
flected light microscope (DMR; Leica, UK). Regions of interest
were identified with reference to a brain atlas (26). Nuclei
positive for c-Fos were counted bilaterally, and the mean
number of c-Fos–positive nuclei per section was calculated for
each rat before a groupmean was calculated. For quantification
of the percentage of oxytocin or TH-immunoreactive cells
expressing c-Fos, the nucleus of each labeled cell was assessed
for c-Fos immunoreactivity. Magnocellular and parvocellular
regions of the PVN were distinguished as described previously
(15). Because the SON only contains oxytocin and vasopressin
neurons, the number of c-Fos–positive nuclei in SON non–
oxytocin-immunoreactive cells was also determined to quantify
c-Fos expression in putative vasopressin cells. Counting was
carried out under blinded conditions by an experienced ex-
perimenter. The same regions of the SON, PVN, and NTS were
counted for each brain. For c-Fos expression in the SON,
sections between bregma 20.72 and 21.08 mm (26) were
counted (four sections per brain). For c-Fos expression in
oxytocin cells of the SON, sections at bregma points 20.84
and20.96mmwere counted (two sections per brain). For c-Fos
expression in the PVN, all sections between bregma 21.56
and 21.92 mm were counted (three sections per brain). For c-
Fos expression in oxytocin cells of the PVN, sections at bregma
points 21.72 and 21.80 mm were counted (two sections per
brain). For c-Fos expression in the NTS, all sections between
bregma 213.68 and 214.16 mm were counted (four sections
per brain). For c-Fos expression in TH cells of the NTS, sections
at bregma points 213.92 and 214.04 mm were counted
(two sections per brain). Differences in c-Fos expression and
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percentage of oxytocin or TH-immunoreactive neurons expressing
c-Fos–positive nuclei between groups were determined using
Mann-Whitney tests.
Experiment 2: c-Fos–like immunohistochemistry
after SCM gavage in anesthetized rats
Rats were fasted overnight for 16 to 18 hours to empty the
stomach. Anesthesia was induced using isoflurane followed by an
intraperitoneal injection of pentobarbital sodium (60 mg/kg).
Once rats were deeply anesthetized, a femoral vein was cannu-
lated to allow the maintenance of anesthesia by continuous in-
fusion of sodium pentobarbital (18.6 mg/kg/h) in 0.9%w/v saline
(10mL/kg/h).Ratswere tracheotomized, and aplastic gavage tube
(FTP-13-150; Solomon Scientific) was inserted via the mouth into
the stomach. After at least 2 hours, 5 mL of SCM was infused
slowly (0.14 mL/min) into the stomach via gavage tube (n = 8;
“SCM gavage”). A second group of rats were subjected to a sham
gavage. These animals were treated the same as those receiving
SCM; however, nothing was infused (n = 8; “sham gavage”). To
control for gastric distention, a final group of rats were subjected
to the inflation of a fine latex balloon attached to the bottomof the
gavage tube (n = 9; “balloon gavage”). The balloon was inflated
with 5 mL water at the same rate as the SCM gavage.
One hour after the end of sham, balloon, or SCM gavage,
rats were given an overdose of pentobarbital sodium via the
femoral vein cannula, perfused transcardially, and processed for
immunochemistry as described previously. Differences in c-Fos
expression and percentage of oxytocin or TH-immunoreactive
neurons expressing c-Fos–positive nuclei between groups were
determined using one-way analysis of variance with Bonferroni.
Experiment 3: Blood sampling during SCM or cream
gavage in anesthetized rats
In a separate cohort ofmale adult pentobarbital-anesthetized
rats undergoing SCM gavage, blood samples were collected
via a jugular cannula filled with heparinized saline (50 U/mL)
into EDTA-coated tubes at time 220, 0, 20, 60 minutes with
respect to start of sham (n = 3) or SCM (n = 4) gavage. An
additional group of rats were gavagedwith 5mL of single cream
(n = 5), and blood was sampled. At each time point, blood
glucose was measured using a glucose meter (ACCU-CHEK
Aviva; Roche, Germany). Samples were centrifuged at 13,000
RPM at room temperature for 10 minutes, and plasma was
collected. Plasma insulin was measured by ELISA (rat/mouse
insulin ELISA) (EZRMI-13K; Merck Millipore). Intra-assay
variability was ,9%. Plasma osmolarity was measured using
an osmometer (Model 3300; Advanced Instruments, Inc.,).
Plasma sodium was measured using a flame photometer (PFP7;
Jenway, UK). Plasma samples were diluted in deionized water (1:
500), and the sodium concentrations were interpolated from a
standard curve (Na, 0 to 10 mg/L). Friedman tests with Dunn
multiple comparisons were used to compare differences in blood
glucose, plasma insulin, plasma osmolarity, and plasma sodium
over time within the sham, cream, and SCM gavage groups.
Experiment 4: In vivo electrophysiology during SCM
or cream gavage in anesthetized rats
c-Fos–like immunoreactivity is only an indirect indicator of
neural activity, and its expression is not necessarily associated
with an increase in action potential firing (20). To examine
neuronal activity directly, we used in vivo electrophysiology to
record from oxytocin and vasopressin neurons in the SON of
anesthetized rats during SCM gavage. SON oxytocin cells were
also recorded from during single cream gavage.
Adult male rats were anesthetized with urethane (1.25 g/kg,
IP), and a femoral vein and the trachea were cannulated. The
SON and neural stalk of the pituitary were exposed by trans-
pharyngeal surgery. A gavage tube was inserted orally into the
stomach to allow infusion of 5 mL SCM or cream directly into
the stomach using a syringe pump (0.14 mL/min). A bipolar
stainless steel electrode was placed on the neural stalk, and a glass
microelectrode filled with 0.9% NaCl was introduced into the
SON under direct visual control. Single SON neurons were
identified antidromically and recorded using conventional ex-
tracellular recording techniques.Oxytocin cellswere distinguished
from vasopressin cells by their opposite response to intravenous
CCK (20 mg/kg; octapeptide, sulfated) (Tocris, UK) (27, 28).
We set a change of 0.5 spikes/s as a threshold above which the
cell was considered as responsive to the substance applied. Cells in
which the change in mean firing rate was less than 60.5 spikes/s
after gavage were categorized as nonresponding cells. For cells that
showed a change of.0.5 spikes/s after gavage, themean activity in
30-second bins in the 10minutes before gavagewas comparedwith
activity in the50-minuteperiodbetween10and60minutes after the
start of gavage, using Student t test, accepting P , 0.001 as sig-
nificant. The mean change in firing rate in the period 10 to 60
minutes after the start of gavagewas tested for thewhole population
of oxytocin cells to check whether, as a population response, this
change was significantly different from 0. For this, we used a
Wilcoxon signed rank test, accepting P , 0.05 as significant.
Table 1. Antibodies Used
Peptide/Protein
Target
Antigen
Sequence Name of Antibody
Manufacturer,
Catalog No., or
Name of Source
Species Raised
in; Monoclonal
or Polyclonal Dilution Used
Research
Resource
Identifier
c-Fos Unknown Anti–c-Fos Synaptic Systems,
226 003
Rabbit;
polyclonal
1 in 100,000 AB_1966442
Oxytocin-
neurophysin
Unknown PS 38 Supplied by H. Gainer Mouse;
monoclonal
1 in 5000 AB_2315026
Tyrosine
hydroxylase
Unknown Anti-tyrosine hydroxylase
antibody, clone LNC1
Merck Millipore,
MAB318
Mouse;
monoclonal
1 in 20,000 AB_2201528
Rabbit IgG Unknown Biotinylated horse
anti-rabbit IgG Antibody
Vector Laboratories,
BA-1100
Horse 1 in 500 AB_2336201
Mouse IgG Unknown Biotinylated horse
anti-mouse IgG antibody
Vector Laboratories,
BA-2000
Horse 1 in 500 AB_2313571
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Results
Experiment 1: c-Fos–like immunohistochemistry
after voluntary SCM consumption
We quantified c-Fos expression as a marker of neural
activation in response to the voluntary consumption of
SCM. In the SON, the percentage of oxytocin neurons
expressing c-Fos was significantly greater in rats voluntarily
consuming SCM in comparison with controls (control, 36
1%; SCM, 236 3%; P = 0.0012) [Fig. 1(a) and 1(b)]. The
SON contains only oxytocin and vasopressin neurons, so
we classified cells thatwere not oxytocin immunoreactive as
putative vasopressin neurons. In comparison with controls,
therewas no significant difference in the number of putative
vasopressin cells expressing c-Fos when rats voluntarily ate
SCM (control, 16 6 2 nuclei/section; SCM, 22 6 1 nuclei/
section; P = 0.14).
In the PVN, the percentage of magnocellular oxytocin
neurons expressing c-Fos significantly increased with
voluntary SCM consumption in comparison with
controls (control, 96 1%; SCM, 286 2%; P = 0.0012)
[Fig. 1(c) and 1(e)]. There was no significant difference
in c-Fos expression in parvocellular PVN oxytocin
neurons between the control and SCM consumption
groups (control, 5 6 1%; SCM, 8 6 2%; P = 0.18)
[Fig. 1(d)].
We also studied other appetite-related brain nuclei. In
the NTS, an important site in the relay of peripheral
signaling to the hypothalamus, the percentage of TH
containing neurons expressing c-Fos significantly in-
creased after the voluntary consumption of SCM (con-
trol, 4 6 0.4%; SCM, 13 6 4%; P = 0.02).
In the ARC and VMH, there were no significant
differences in c-Fos expression after voluntary SCM
consumption in comparison with controls (ARC: control,
78 6 5 nuclei/section; SCM, 118 6 23 nuclei/section;
P = 0.6; VMH: control, 13 6 3 nuclei/section; SCM,
15 6 2 nuclei/section; P = 0.84).
Figure 1. c-Fos–like immunohistochemistry in oxytocin neurons of the SON and PVN in response to the voluntary consumption of SCM. Data
shown as means 6 standard error of the mean. *P , 0.05. (a) Percentage of SON oxytocin-immunoreactive cells expressing c-Fos–positive nuclei
per brain section for control and SCM consumption groups (P = 0.0012, Mann-Whitney test). (b) Representative images of c-Fos expression
within SON oxytocin-immunoreactive cells for control and SCM consumption groups. Bregma 20.84 mm (26). Scale bar represents 10 mm.
(c) Percentage of PVN magnocellular oxytocin-immunoreactive cells expressing c-Fos positive nuclei per brain section for control and SCM
consumption groups (P = 0.0012, Mann-Whitney test). (d) Percentage of PVN parvocellular oxytocin-immunoreactive cells expressing c-
Fos–positive nuclei per brain section for control and SCM consumption groups (Mann-Whitney test, P = 0.17). (e) Representative images of
c-Fos expression within PVN oxytocin-immunoreactive cells for control and SCM consumption groups. Bregma 21.72 mm (26). Main scale bar
represents 50 mm; inset scale bar represents 10 mm. 3V, 3rd ventricle; Magno, magnocellular PVN; Parvo, parvocellular PVN.
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Experiment 2: c-Fos–like immunohistochemistry
after SCM gavage in anesthetized rats
To further investigate this c-Fos response, we developed
an in vivo model to quantify c-Fos expression as a marker
of neural activation in response to sham, balloon, and SCM
gavage in oxytocin neurons of the SON and PVN.
In the SON, the percentage of oxytocin neurons that
expressed c-Fos was significantly higher with SCM gavage
than in either the shamcontrol group or the balloon gavage
group (sham gavage, 196 1%; balloon gavage, 226 3%;
SCM gavage, 38 6 7%; P = 0.02 and P = 0.04, re-
spectively) [Fig. 2(a) and 2(b)], and the balloon gavage
groupwas not significantly different from the sham control
group (P . 0.99) [Fig. 2(a)]. There was no significant
difference in SON c-Fos expression in putative vasopressin
cells between sham gavage and balloon gavage groups
(sham gavage, 87 6 9 nuclei/section; balloon gavage,
1126 18 nuclei/section; P = 0.8) or between sham gavage
and SCM gavage groups (sham gavage, 87 6 9 nuclei/
section; SCM gavage, 142 6 18 nuclei/section; P = 0.08).
The percentage of PVN magnocellular oxytocin-
immunoreactive cells expressing c-Fos was significantly
higher in the SCM gavage group in comparison with the
balloon gavage group (balloon gavage, 8 6 2%; SCM
gavage, 26 6 6%; P = 0.03) [Fig. 2(c) and 2(e)], and
expression in the sham group was not significantly dif-
ferent from either SCM or balloon gavage group (sham
gavage, 16 6 5%; P = 0.7 and P = 0.5 for balloon and
SCM respectively) [Fig. 2(c)]. There was no significant
difference in c-Fos expression in PVN parvocellular
oxytocin neurons between the sham, balloon, and SCM
gavage groups (sham gavage, 35 6 6%; balloon gavage,
32 6 5%; SCM gavage, 35 6 5%; P = 0.9) [Fig. 2(d)].
In the NTS, there were no significant differences in c-
Fos expression between the groups (sham gavage, 2386
22 nuclei/section; balloon gavage, 286 6 33 nuclei/
section; SCM gavage, 247 6 13 nuclei/section; P = 0.4)
or in the percentage of NTS TH-immunoreactive cells
expressing c-Fos (sham gavage, 366 6%; balloon gavage,
43 6 4%; SCM gavage, 41 6 4%; P = 0.5).
Figure 2. c-Fos–like immunohistochemistry in oxytocin neurons within the SON and PVN in response to sham, balloon, or SCM gavage. Data
shown as means 6 standard error of the mean. *P , 0.05. (a) Percentage of SON oxytocin-immunoreactive cells expressing c-Fos–positive
nuclei per brain section for sham, balloon, and SCM gavage groups [P = 0.01, one-way analysis of variance (ANOVA) with Bonferroni]. (b)
Representative images of c-Fos expression within SON oxytocin-immunoreactive cells for sham and SCM gavage groups. Bregma 20.84 mm (26).
Scale bar represents 10 mm. (c) Percentage of PVN magnocellular oxytocin-immunoreactive cells expressing c-Fos–positive nuclei per brain
section for sham, balloon, and SCM gavage groups (P = 0.04, one-way ANOVA with Bonferroni). (d) Percentage of PVN parvocellular oxytocin-
immunoreactive cells expressing c-Fos–positive nuclei per brain section for sham, balloon, and SCM gavage groups (P = 0.9, one-way ANOVA).
(e) Representative images of c-Fos expression within PVN oxytocin-immunoreactive cells for balloon and SCM gavage groups. Bregma 21.72 mm
(26). Main scale bar represents 50 mm; inset scale bar represents 10 mm. 3V, 3rd ventricle; Magno, magnocellular PVN; Parvo, parvocellular PVN.
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In the ARC and VMH, there were no
significant differences in c-Fos expression
between groups (ARC: sham gavage,
49 6 5 nuclei/section; balloon gavage,
366 6 nuclei/section; SCM gavage, 576
5 nuclei/section; P = 0.051; VMH: sham
gavage, 26 6 6 nuclei/section; balloon
gavage, 16 6 4 nuclei/section; SCM ga-
vage, 35 6 6 nuclei/section; P = 0.06).
Experiment 3: Blood sampling
during SCM or cream gavage in
anesthetized rats
Wemeasured blood glucose, plasma
insulin, plasma osmolarity, and plasma
sodium at 220, 0, 20, and 60 minutes
with respect to start of sham, SCM, or
single cream gavage. In the SCM ga-
vage group, blood glucose increased 20
minutes after the start of gavage and
was significantly increased after 60
minutes (P = 0.01 compared with
t = 220 minutes) [Fig. 3(a)]. Blood
glucose levels did not change with time
in the sham or cream gavage groups
(P = 0.91 and P = 0.11, respectively)
[Fig. 3(a)]. In the SCM gavage group,
plasma insulin increased 60 minutes
after the start of gavage; however, this
increase was not significant (P = 0.24)
[Fig. 3(b)]. In the cream gavage group,
plasma insulin was significantly in-
creased 20 and 60 minutes after the
start of gavage (P = 0.04 and P = 0.01,
respectively, compared with t = 220
minutes) [Fig. 3(b)]. Plasma insulin did
not change with time in the sham ga-
vage group (P = 0.91) [Fig. 3(b)]. There were no signif-
icant differences in plasma osmolarity over time in the
sham, SCM, or cream gavage groups (P = 0.61, P = 0.51,
and P = 0.23, respectively) [Fig. 3(c)]. There were also no
significant differences in plasma sodium over time in the
sham, SCM, or cream gavage groups (P = 0.91, P = 0.99,
and P = 0.65, respectively) [Fig. 3(d)].
Experiment 4: In vivo electrophysiology during SCM
or cream gavage in anesthetized rats
Rats were fasted overnight and anesthetized with
urethane. For SCM gavage, we recorded data from nine
SON oxytocin neurons and nine SON vasopressin neu-
rons (of which five fired phasically and four fired con-
tinuously). Every nonphasic cell was tested with an
intravenous injection of CCK after the gavage. Cells that
were activated by CCK were classed as oxytocin cells
[Fig. 4(a)], whereas cells that were inhibited were con-
sidered vasopressin cells. During single cream gavage, we
recorded from six SON oxytocin neurons.
After 10minutes of stable, basal recording of the mean
firing rate in a single cell, we started gavage of 5 mL SCM
or cream directly into the stomach and recorded the effect
of firing rate throughout the gavage, which lasted about
35 minutes. In most cells, recordings were maintained up
to 20 minutes after the gavage had finished.
At the beginning of SCM gavage, the mean firing rate
of the nine oxytocin cells was 4.96 1.2 spikes/s. Seven of
these cells showed an increase in mean firing rate within
10 minutes of the start of gavage. Between 10 and 20
minutes after the start of gavage, the overall mean rate
was significantly higher than the basal rate [Fig. 4(b)].
Figure 3. Blood glucose, plasma insulin, plasma osmolarity, and plasma sodium at time
points 220, 0, 20, and 60 minutes with respect to the start of sham, SCM, or single cream
gavage. Data shown as means 6 standard error of the mean. (a) Time course of blood
glucose (mM/L) for sham, SCM, and cream gavage groups. *P , 0.05 [Friedman test with
Dunn multiple comparisons for the SCM (P = 0.0006) gavage group over time; Friedman test
for sham (P = 0.91) or cream (P = 0.11) gavage groups over time]. (b) Time course for plasma
insulin (ng/mL) for sham, SCM, and cream gavage groups. *P , 0.05 [Friedman test with
Dunn multiple comparisons for the cream gavage group over time (P = 0.0087); Friedman
test for SCM (P = 0.24) or sham (P = 0.91) gavage groups over time]. (c) Time course of
plasma osmolarity (mOsm) for sham, SCM, or cream gavage groups [Friedman test for the
sham (P = 0.61), SCM (P = 0.51), or cream (P = 0.23) gavage groups over time]. (d) Time
course of plasma sodium (mg/L) for sham, SCM, or cream gavage groups [Friedman test for
the sham (P = 0.91), SCM (P = 0.99), or cream (P = 0.65) gavage groups over time].
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The mean firing rate increased linearly with duration of
gavage, with a slope of 0.042 spikes/s/min (R2 = 0.9)
[Fig. 4(c)]. This increase lasted until the end of gavage,
reaching a plateau between 40 and 60 minutes after the
start of gavage. The mean change averaged over the 50-
minute period between 10 and 60 minutes after gavage
started was 1.26 0.3 spikes/s (P = 0.004). In response to
CCK, the nine cells increased their firing rate by 1.3 6
0.24 spikes/s in the first 5 minutes after injection [Fig.
4(d)]; the magnitude of the response to CCK was not
significantly correlated with the response to gavage
(R2 = 0.02).
In vasopressin cells, we combined the recordings from
phasic-firing [Fig. 5(a)] and continuous-firing cells and
analyzed the mean difference in firing rate in 10-minute
bins in response to SCM gavage. Seven of the nine cells
increased their firing rate within 10minutes of the start of
the gavage. Between 10 and 20 minutes after the start of
gavage, the overall mean rate was significantly higher
than the basal rate. The mean change averaged over the
50-minute period between 10 and 60 minutes after ga-
vage started was +1.4 6 0.5 spikes/s (from a mean basal
firing rate of 5.4 6 0.5 spikes/s; P = 0.008) [Fig. 5(b)].
During cream gavage, four of the six oxytocin cells
were responsive. The change in firing rate in response to
gavage exceeded 0.5 Hz. In these cells, there was a
decrease in the mean firing rate within 5minutes of cream
gavage, and the overall mean rate was significantly lower
than the basal rate between 5 and 30 minutes after the
start of gavage, reaching a maximum decrease at
30 minutes before starting to recover its original level
(P , 0.001) [Fig. 6(a)]. Two of the six cells were con-
sidered unresponsive to single cream gavage (mean
change in firing rate ,0.5 Hz). Overall, before gavage,
the mean basal firing rate in the six oxytocin cells was
2.4 6 0.52 spikes/s, and the mean change averaged over
the 25-minute period between 5 and 30 minutes after
gavage started was –0.576 0.31 spikes/s [Fig. 6(b)]. This
decrease in firing rate in response to cream in the aver-
aged six cells was not significant (P = 0.156).
Discussion
We studied the involvement of oxytocin neurons in the
response to food consumption or gavage using c-Fos
immunoreactivity and in vivo electrophysiology. Sati-
ated rats that voluntarily consumed SCM showed in-
creases in c-Fos expression in magnocellular SON and
PVN neurons. To avoid confounding from oro-sensory
signaling (12), we used oral gavage to instill SCMdirectly
into the stomach and found the same pattern of c-Fos
expression in the SON and PVN. We confirmed previous
Figure 4. Effects of SCM gavage on the electrical activity of oxytocin neurons in the SON of rats in vivo. (a) Typical example of the increase in
the mean firing rate in an oxytocin cell in response to SCM gavage and excitation in response to subsequent intravenous injection of CCK.
(b) Mean changes in the firing rate (in 30-second bins) in oxytocin cells in response to gavage of SCM [n = 9; 6 standard error of the mean
(SEM)]. (c) The linear regression line fitted to the mean changes in firing rate plotted in b. (d) Mean change in firing rate in 30-second bins in
the oxytocin cells in response to CCK (n = 9; 6 SEM).
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observations of c-Fos protein expression in the PVN after
voluntary consumption of food (29) and extended ob-
servations of c-Fos mRNA expression in the SON after
voluntary consumption or conscious gavage of SCM
(12). We used double-label immunohistochemistry for
c-Fos and oxytocin and found increased c-Fos expression
in SON and PVN magnocellular oxytocin neurons after
voluntary consumption or gavage of SCM.
Gastric distention has been shown to induce SON c-Fos
immunoreactivity and to increase the electrical activity of
SON oxytocin neurons (14, 27). With this in mind, we
controlled for distention by inflating a balloon at the same
rate and volume as in food gavage.We foundnodifferences
in c-Fos immunoreactivity in SON oxytocin neurons be-
tween the sham and balloon gavage groups. We did not
record the electrical activity of SON oxytocin neurons in
response to gastric distention, but the initial increase in
firing rate with SCM gavage is unlikely due to gastric
distention as the electrical response occurs very soon after
gavage onset, before appreciable distention can occur.
In the rat, oxytocin neurons are osmosensitive (30) and
receive input from osmosensitive brain regions (31), and
oxytocin is secreted peripherally in response to osmotic
stimuli and promotes sodium excretion (32, 33). We did
not measure plasma oxytocin in this study, but neither
plasma osmolarity nor plasma sodium was altered by
SCM gavage, so it is unlikely that these served as stimuli
for the observed increase in firing rate.
The expression of c-Fos in a given cell does not nec-
essarily reflect a change in electrical activity (20). To
study electrical responses directly, we used in vivo elec-
trophysiology and identified SON oxytocin neurons
pharmacologically. Consistent with the c-Fos mapping
studies, the firing rate of SONoxytocin neurons increased
during gavage of SCM, a high-sugar food. However,
gavage of isocaloric cream was not associated with an
increase in firing rate, showing that high-sugar, but not
high-fat, food in the stomach increases the electrical
activity of oxytocin neurons.
We observed a strong association between the time
since the start of SCM gavage and the mean firing rate of
oxytocin neurons. These neurons responded very rapidly
to the onset of SCM gavage, their response was linear and
proportional to the amount of SCM gavaged, and the
Figure 5. Effects of SCM gavage on the electrical activity of vasopressin neurons in the SON of rats in vivo. (a) Example of the response of
a phasically firing vasopressin neuron in response to SCM gavage (firing rate in 10-second bins) with extract of raw voltage signal showing
recorded action potentials. (b) Mean change in firing rate in vasopressin cells in 10-minute bins in response to SCM gavage (n = 9; 6 standard
error of the mean).
Figure 6. Effects of single cream gavage on the electrical activity of oxytocin neurons in the SON of rats in vivo. (a) Typical example of the
response of an oxytocin cell to single cream gavage. (b) Mean change in firing rate (in 30-second bins) in oxytocin cells in response to single
cream gavage (n = 6; 6 standard error of the mean).
doi: 10.1210/en.2016-1640 https://academic.oup.com/endo 2207
increased firing rate persisted after the offset of gavage.
This in vivo electrophysiological response is similar to
that seen in rat oxytocin and vasopressin SON neurons
during infusion of hypertonic saline (34) and provides
further evidence for a role for these neurons in accurately
encoding variations in physiological stimuli.
There is emerging evidence for SON oxytocin neurons
as “metabolic sensors.” The SON expresses insulin re-
ceptors and glucokinase, an enzyme considered to play a
critical role in glucose-sensitive cells of the brain, pan-
creas, and liver. In an in vitro model, glucose and insulin
stimulated oxytocin release from explants containing the
SON (35, 36). However, in in vitro slice preparations,
SON neurons do not increase their firing rate in response
to increased glucose in the perifusion medium (30), and
intravenous infusion of glucose results in an increase in c-
Fos expression in the rat PVN but not SON (37). In our
study, we did not measure cerebrospinal fluid glucose
levels; however, after SCM gavage, plasma glucose levels
began to increase soon after the onset of gavage and were
significantly increased 60 minutes after the start of ga-
vage. Firing rates in oxytocin cells showed a similar
pattern, reaching a maximum around 30 minutes after
the onset of gavage. In addition, we observed no change
in blood glucose after cream gavage and no increase in
firing rates in oxytocin cells.
We alsomeasured plasma insulin levels during gavage.
There was a large variation in values at 220 minutes in
the SCM group, but plasma insulin levels appear to in-
crease during SCM gavage. After cream gavage, plasma
insulin levels were also increased but not to the same
extent. These data support the idea that increases in
glucose or insulin may be an important stimulus for the
oxytocin system. It would be of interest to measure ce-
rebrospinal fluid glucose and insulin levels during food
gavage and to determine whether centrally or peripher-
ally administered glucose or insulin given at physiolog-
ically relevant doses affects the firing rate of SON
neurons.
Magnocellular oxytocin neurons from the SON and
PVN can secrete oxytocin into the circulation from
projections to the posterior pituitary and can in-
dependently secrete centrally via dendritic release (2, 20).
If specific activation of the magnocellular system by SCM
gavage is sufficient to stimulate oxytocin release, both
peripheral and central oxytocin secretion may occur. We
did not measure plasma oxytocin, but there is a small
body of evidence suggesting that oxytocin is released
peripherally in response to food consumption: plasma
oxytocin increases after the onset of feeding in food re-
stricted rats and in response to intragastric infusion of
milk in 10-day-old rat pups (38, 39). Given the apparent
role for magnocellular cells and an apparent lack of
activation of parvocellular cells in our model, it would be
of interest to determine whether oxytocin is released
centrally and/or peripherally in response to food in the
stomach and to determine which sites of action, both in
the brain and in peripheral tissues, are involved in this
response. One potential brain target is the VMH. The
VMH contains oxytocin binding sites (40), and targeted
administration of oxytocin to the VMH results in in-
creased energy expenditure and reduced feeding (1). We
observed a nonsignificant increase in c-Fos expression in
the VMH after SCM gavage, but it is not clear whether
this represents a direct downstream effect of central
oxytocin release after SCM gavage or is related more
broadly to satiety signaling (41).
Putative SON vasopressin neurons showed a small,
nonsignificant increase in c-Fos expression with volun-
tary SCM consumption and SCM gavage. We also
showed a transient increase in the firing rate of phar-
macologically identified vasopressin neurons during
SCM gavage. This response was qualitatively different
from that seen in oxytocin cells. Firing rates in vaso-
pressin cells increased during SCM gavage, but this in-
crease was not sustained at the offset of gavage. An
increase in c-Fos immunoreactivity in SON vasopressin
neurons in response to refeeding after food restriction
was previously noted (11). However, this is likely due to
an osmotic stimulus (42). We have shown that plasma
osmolarity and plasma sodium concentrations do not
change with SCM gavage. Therefore, an osmotic effect is
unlikely to underlie the response of vasopressin or oxy-
tocin neurons to SCM ingestion in our experiments.
There is little evidence for a role of vasopressin neurons in
appetite control (43, 44). The mechanisms underlying a
potential role of vasopressin in appetite control remains
unknown; unlike oxytocin neurons, SON vasopressin
neurons do not appear to be innervated by NTS pro-
jections and are inhibited by the satiety signal CCK (28).
There are multiple mechanisms by which gut-initiated
signaling could influence the activity of oxytocin neurons.
It is possible that the increase in oxytocin neuron activity
in response to SCMgavage ismediated byCCK, a peptide
signal released in response to nutrients entering the du-
odenum of the small intestine. CCK acts via vagal af-
ferents to activate noradrenergic projections from the
NTS to magnocellular oxytocin neurons, resulting in
oxytocin release from the posterior pituitary (45–47). We
quantified c-Fos immunoreactivity in the NTS and in
particular in neurons immunoreactive for TH. In rats that
consumed SCM voluntarily, we saw an increase in c-Fos
expression within TH-immunoreactive cells in the NTS.
Therefore, it is possible that, after the consumption of
SCM, CCK secreted from the gut activates vagal afferents
to activate noradrenergic neurons in the NTS. Activation
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of noradrenergic NTS projections to the SON and PVN
may subsequently influence the activity of oxytocin
neurons.
Glucagonlike peptide 1 (GLP-1) is also released from
the gut in response to nutrients and is thought to
mediate a satiety effect through vagal neurons and the
NTS (48). The effects of peripheral GLP-1 on the activity
of oxytocin neurons have not been well characterized;
however, peripheral administration of GLP-1 results in c-
Fos expression in the SON (49), whereas central injection
of GLP-1 induces c-Fos expression in both PVN and SON
magnocellular neurons (50). There is evidence for com-
plex effects of GLP-1 on peripheral oxytocin release that
depend on the model system and the dose and route of
administration (51, 52). There is also evidence for central
sources of GLP-1 (53), and behavioral studies using
central administration in rats have resulted in opposing
effects of blockade of GLP-1 receptors on the anorexi-
genic effects of oxytocin administration (51, 54). However,
oxytocin receptor blockade does not prevent GLP-1–
induced reductions in food intake (51). Given our obser-
vations of differing electrophysiological responses using
isocaloric foods with different macronutrient profiles, it
would be of interest to determine the signaling mechanisms
that appear to detect different macronutrients and convey
information about the macronutrient profile from the gut
to the brain.
The activity of oxytocin neurons could also be influ-
enced by centrally released appetite-associated signals.
ARC pro-opiomelanocortin neurons project to both the
SON and PVN (55), which express the melanocortin
MC4 receptor (56). Many studies demonstrate that
melanocortin signaling, particularly in the PVN, plays a
fundamental role in appetite control (57). Despite this, a
recent study has shown that re-expression of the MC4
receptor, specifically in PVN oxytocin neurons in MC4
knock-out mice, does not reverse the obesity phenotype
seen in these animals (58). However, this study does not
address a potential role for SON oxytocin neurons. We
have previously shown that central administration of the
endogenous MC4 receptor agonist a-MSH increases
c-Fos expression in SON oxytocin neurons and induces
central release of oxytocin from their dendrites (20). In
that study we also showed that a-MSH inhibits the
electrical activity of SON oxytocin neurons and pe-
ripheral oxytocin secretion from the posterior pituitary.
Therefore, the importance of peripheral and central
oxytocin secretion in response to food consumption
remains unclear.
In our gavage experiments, it is possible that taste-
independent, postingestive reward signaling may influ-
ence the activity of oxytocin neurons. Neither the ventral
tegmental area (59) nor the nucleus accumbens (60) of the
mesolimbic reward system directly project to the SON or
PVN in the rat. However, other appetite-associated brain
regions implicated in communicating with the reward
system, for example the NTS, project to the SON and
PVN. Therefore, reward signaling after food ingestion
may indirectly activate oxytocin neurons.
We also quantified c-Fos expression in a number of
other appetite-related brain regions. It has been shown
that c-Fos expression increases in the ARC, VMH, and
NTS after refeeding in fasted rats (11). We did not ob-
serve this in our model. However, it would be of interest
to determine whether specific cell types within these re-
gions respond to SCM gavage, particularly given the
potential role of the VMH as a target for oxytocin
signaling.
In summary, we provide evidence for differential ac-
tivation of SON oxytocin neurons by isocaloric foods in
the stomach.We observed an increase in electrical activity
in these cells after gavage of high-sugar, but not high-fat,
food. Activation is independent of oro-sensory signaling,
gastric distention, and plasma osmolarity or plasma so-
dium levels. SON oxytocin cells show a remarkably rapid,
linear, and proportional excitatory response during SCM
gavage, and this response is stable and sustained after the
end of gavage. This indicates these cells may have a dy-
namic role in appetite signaling.
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